Liu Q, Zhou BM, Wang LJ, Zhang CY. Construction of a hierarchical DNA circuit for single-molecule profiling of locus-specific N
6-methyladenosine-MALAT1 in clinical tissues.
Biosens Bioelectron 2025;
274:117198. [PMID:
39893948 DOI:
10.1016/j.bios.2025.117198]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2024] [Revised: 01/16/2025] [Accepted: 01/25/2025] [Indexed: 02/04/2025]
Abstract
N6-methyladenosine (m6A) is the most important internal methylation in eukaryotic RNAs, and it is critically implicated in diverse RNA metabolisms for cancer development. Because epigenetic modifications do not interfere with Watson-Crick base pairing and m6A modification is not susceptible to chemical decorations, standard hybridization-based techniques cannot be applied for sensing m6A in RNAs. Consequently, the development of new methods for accurate and sensitive profiling of locus-specific m6A in RNAs remains a great challenge. Herein, we demonstrate for the first time the construction of a hierarchical DNA circuit for single-molecule profiling of locus-specific m6A-metastasis-associated lung adenocarcinoma transcript 1 (m6A-MALAT1) in clinical tissues. Taking advantage of high discrimination of VMC10-DNAzyme between m6A and A, exponential efficiency of hierarchical DNA circuit, and ultrahigh signal-to-noise ratio of single-molecule detection, this nanodevice exhibits attomolar sensitivity with a limit of detection (LOD) of 1.8 aM for m6A-MALAT1 in vitro and a dynamic range of 7 orders of magnitude. Moreover, it can discriminate 0.001% m6A-MALAT1 from excess A-MALAT1, quantify m6A-MALAT1 in diverse cancer cells at single-cell level, distinguish m6A-MALAT1 expressions in breast cancer patients and healthy individuals, and monitor cellular m6A-MALAT1 for gene therapy, offering a promising platform for epitranscriptomic research and clinical diagnostics.
Collapse